The Leading Gathering of Litigation and MDL Defense Counsel in the Life Science’s Industry
This event is your chance to connect with hundreds of products liability defense stakeholders from industry, private practice, and the Bench. Take advantage of extended networking opportunities and engage in interactive discussions to collaborate and strategize on the current products liability landscape and what lies ahead.
Join us this December to meet and reconnect with your colleagues and industry trailblazers. Gain invaluable insights through two full days of interactive discussions on the most critical product liability litigation challenges facing the drug and medical device community today. Our esteemed 2024 faculty will provide essential information on the product liability risks associated with AI in drug development, medical device usage, and litigation strategies.
We will also cover the impact of new MDL case management changes, navigating the new Rule 702 amendments, the benefits and risks of utilizing bankruptcy as a mass tort resolution vehicle, litigation exit strategies, and much more. Our content-rich program and sophisticated panel discussions will give you real-world insights on the most critical international developments impacting drug and device product liability litigation. Don’t miss out on the drug and medical device litigation defense bar’s most valuable gathering of the year!
What to Expect
Expert Faculty: Each year, the conference features top-notch, experienced in-house counsel, renowned defense practitioners, and distinguished jurists.
Proactive Defense Tools: Attendees gain the necessary tools to effectively defend against an increasingly aggressive plaintiffs’ bar and heightened public and political scrutiny.
Networking Opportunities: Join industry veterans and first-timers alike to learn and network.
Highlights
Record-Breaking Attendance: Last year’s event saw 400+ industry professionals in attendance.
Premier Status: Recognized as the leading forum for drug and medical device product liability litigation.
29th Anniversary: This year’s event promises to continue the tradition of excellence.
Past Esteemed Conference Chairs
Many of the industry’s leading drug and medical device counsel have lent their time and expertise to help pioneer this flagship event. Here is a look at some of our event co-chairs whose dedication have allowed this conference to grow into the premier products liability litigation event for the pharmaceutical and medical device industries for nearly 30 years.
Sonia Arnold
General Counsel – Lilly Oncology, Eli Lilly and Company
Max Heerman
Senior Legal Counsel, Litigation, Medtronic
Bradley E. Lerman
General Counsel, Medtronic
Gary McConnell
Vice President, Associate General Counsel, Bayer
Rita McConnell (ret.)
Vice President, Chief Litigation Counsel, Medtronic
Monique Hunt McWilliams
Assistant General Counsel, Eli Lilly and Company
Michael Parini
Executive VP, Chief Legal Officer, Vertex Pharmaceuticals
Sarah Padgitt
Associate General Counsel, Baxter International
William J. Ruane
Vice President, Associate General Counsel – Litigation, Wyeth